| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |